Response of adipose tissue to early infection with trypanosoma cruzi (Brazil Strain)

Journal of Infectious Diseases

Volumn 205, Issue 5, 2012, Pages 830-840

  Nagajyothi, Fnu ^a   Desruisseaux, Mahalia S ^a,b   MacHado, Fabiana S ^c   Upadhya, Rajendra ^a   Zhao, Dazhi ^a   Schwartz, Gary J ^a,b   Teixeira, Mauro M ^c   Albanese, Chris ^d   Lisanti, Michael P ^e   Chua, Streamson C ^a,b   Weiss, Louis M ^a,b   Scherer, Philipp E ^f,g   Tanowitz, Herbert B ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Diabetes Research and Training Center   (United States)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d GEORGETOWN UNIVERSITY   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f Touchstone Diabetes Center   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BACTERIAL PROTEIN; GAMMA INTERFERON; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 17; INTERLEUKIN 17BETA; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBRANE 1 BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BODY FAT DISTRIBUTION; BRAZIL; BROWN ADIPOSE TISSUE; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE DURATION; FAT CONTENT; LIPID ANALYSIS; LIPID STORAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; CHAGAS DISEASE; CHEMOKINES; CYTOKINES; I-KAPPA B KINASE; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PPAR GAMMA; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TRYPANOSOMA CRUZI;

EID: 84055202591     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir840     Document Type: Article

References (47)

1. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006; 55:1537-45. (Pubitemid 44324105)
2. Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinol Metab 2008; 37:753-68.
3. Rajala MW, Scherer PE. Minireview: the adipocytedat the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144:3765-73. (Pubitemid 37088727)
4. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96:939-49. (Pubitemid 40712793)
5. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115:911-19.
6. Anderson EK, Gutierrez DA, Hasty AH. Adipose tissue recruitment of leukocytes. Curr Opin Lipidol 2010; 21:172-7.
7. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11:85-97.
8. Desruisseaux MS, Nagajyothi , Trujillo ME, Tanowitz HB, Scherer PE. Adipocyte, adipose tissue, and infectious disease. Infect Immun 2007; 75:1066-78. (Pubitemid 46385798)
9. Pajvani UB, Trujillo ME, Combs TP, et al. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 2005; 11:797-803. (Pubitemid 41021214)
10. Kopp A, Buechler C, Neumeier M, et al. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity 2009; 17:648-56.
11. Tanowitz HB, Machado FS, Jelicks LA, et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 2009; 51:524-39.
12. TanowitzHB, Kirchhoff LV, Simon D, Morris SA,Weiss LM,Wittner M. Chagas' disease. Clin Microbiol Rev 1992; 5:400-19.
13. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 2010; 115:22-7.
14. Sartori AM, Ibrahim KY, Nunes Westphalen EV, et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 2007; 101:31-50. (Pubitemid 47488082)
15. Kun H, Moore A, Mascola L, et al. Chagas Disease in Transplant Recipients Investigation Team. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 2009; 48:1534-40.
16. Barcán L, Luna C, Clara L, et al. Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas' disease. Liver Transpl 2005; 11:1112-16; (Pubitemid 41341762)
17. Erratum in: Liver Transpl. 2005; 11: 1617.
18. Huang H, Chan J, Wittner M, et al. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol 1999; 31:75-88. (Pubitemid 29078220)
19. Machado FS, Souto JT, Rossi MA, et al. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 2008; 10:1558-66.
20. Shoemaker JP, Hoffman RV Jr, Huffman DG. Trypanosoma cruzi: preference for brown adipose tissue in mice by the Tulahuen strain. Exp Parasitol 1970; 27:403-7.
21. Shoemaker JP, Hoffman RV Jr. Trypanosoma cruzi: possible stimulatory factor(s) on brown adipose tissue of mice. Exp Parasitol 1974; 35:272-4.
22. Andrade ZA, Silva HR. Parasitism of adipocytes by Trypanosoma cruzi. Mem Inst Oswaldo Cruz 1995; 90:521-2.
23. Combs TP, Nagajyothi , Mukherjee S, et al. The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem 2005; 280:24085-94. (Pubitemid 40884896)
24. Nagajyothi F, Desruisseaux MS, Thiruvur N, et al. Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity 2008; 16:1992-7.
25. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270:26746-9.
26. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20.
27. Gazzinelli RT, Denkers EY. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 2006; 6:895-906. (Pubitemid 44851732)
28. Camps M, Nichols A, Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 2000; 14:6-16. (Pubitemid 30051518)
29. Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Inter J Biochem Cell Biol 2008; 40:2707-19.
30. Avruch J. MAP kinase pathways: the first twenty years. Biochem Biophys Acta 2007; 1773:1150-60. (Pubitemid 47125973)
31. Huang H, Petkova SB, Cohen AW, et al. Activation of transcription factors AP-1 and NF-jB in murine chagasic myocarditis. Infect Immun 2003; 71:2859-67. (Pubitemid 36519899)
32. Mukherjee S, Huang H, Petkova SB, et al. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun 2004; 72:5274-82. (Pubitemid 39223414)
33. Tarleton RL. Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol 2007; 19:430-4. (Pubitemid 47284855)
34. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 2004; 38:943-50. (Pubitemid 38457201)
35. Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J. Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 2008; 19:130-7. (Pubitemid 351608304)
36. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-a. Cytokine Growth Factor Rev 2003; 14:447-55. (Pubitemid 37099456)
37. Yudkin JS. Inflammation, obesity, and the metabolic syndrome. Horm Metab Res 2007; 39:707-9. (Pubitemid 350099816)
38. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-808. (Pubitemid 38063703)
39. Kosteli A, Sugaru E, Haemmerle G, et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 2010; 120:3466-79.
40. Kusminski CM, Scherer PE. The road from discovery to clinic: adiponectin as a biomarker of metabolic status. Clin Pharmacol Ther 2009; 86:592-5.
41. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophysl Res Commun 1999; 257:79-83. (Pubitemid 29299050)
42. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-jB signaling through a cAMPdependent pathway. Circulation 2000; 102:1296-301.
43. Zhang B, Berger J, Hu E, et al. Negative regulation of Peroxisome Proliferation Activated Receptor-c gene expression contributes to the antiadipogenic effects of tumor necrosis factor-a. Mol Endocrinol 1996; 10:1457-66. (Pubitemid 26423234)
44. Appel S, Mirakaj V, Bringmann A,Weck MM, Grünebach F, Brossart P. PPAR-c agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-jB pathways. Blood 2005; 106:3888-94. (Pubitemid 41739028)
45. Ferreira AV, Segatto M, Menezes Z, et al. Evidence for Trypanosoma cruzi in adipose tissue in human chronic Chagas disease. Microbes Infect 2011; 13:1002-5.
46. Shimano M, Ouchi N, Shibata R, et al. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. J Mol Cell Cardiol 2010; 49:210-20.
47. Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J 2009; 73:608-14.